Association Between Chondrolabral Junction Breakdown and Conversion to Total Hip Arthroplasty After Hip Arthroscopy for Symptomatic Labral Tears: Minimum 8-Year Follow-up.

FAI arthroscopic labral repair chondrolabral junction femoroacetabular impingement hip arthroscopy long-term outcomes

Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
12 Mar 2024
Historique:
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

Arthroscopic treatment of femoroacetabular impingement (FAI) and symptomatic labral tears confers short- to midterm benefits, yet further long-term evidence is needed. Moreover, despite the physiological and biomechanical significance of the chondrolabral junction (CLJ), the clinical implications of damage to this transition zone remain understudied. To (1) report minimum 8-year survivorship and patient-reported outcome measures after hip arthroscopy for FAI and (2) characterize associations between outcomes and patient characteristics (age, body mass index, sex), pathological parameters (Tönnis angle, alpha angle, type of FAI, CLJ breakdown), and procedures performed (labral management, FAI treatment, microfracture). Cohort study; Level of evidence, 3. This retrospective cohort study included patients who underwent primary hip arthroscopy for symptomatic labral tears secondary to FAI by a single surgeon between 2002 and 2013. All patients were ≥18 years of age with minimum 8-year follow-up and available preoperative radiographs. The primary outcome was conversion to total hip arthroplasty (THA), and secondary outcomes included revision arthroscopy, patient-reported outcome measures, and patient satisfaction. CLJ breakdown was assessed using the Beck classification. Kaplan-Meier estimates and weighted Cox regression were used to estimate 10-year survivorship (no conversion to THA) and identify risk factors associated with THA conversion. In this study of 174 hips (50.6% female; mean age, 37.8 ± 11.2 years) with mean follow-up of 11.1 ± 2.5 years, the 10-year survivorship rate was 81.6% (95% CI, 75.9%-87.7%). Conversion to THA occurred at a mean 4.7 ± 3.8 years postoperatively. Unadjusted analyses revealed several variables significantly associated with THA conversion, including older age; higher body mass index; higher Tönnis grade; labral debridement; and advanced breakdown of the CLJ, labrum, or articular cartilage. Survivorship at 10 years was inferior in patients exhibiting severe (43.6%; 95% CI, 31.9%-59.7%) versus mild (97.9%; 95% CI, 95.1%-100%) breakdown of the CLJ ( Although most patients achieved favorable minimum 8-year outcomes, several pre- and intraoperative factors were associated with THA conversion; of these, worse CLJ breakdown, higher Tönnis grade, and older age were the strongest predictors.

Sections du résumé

BACKGROUND UNASSIGNED
Arthroscopic treatment of femoroacetabular impingement (FAI) and symptomatic labral tears confers short- to midterm benefits, yet further long-term evidence is needed. Moreover, despite the physiological and biomechanical significance of the chondrolabral junction (CLJ), the clinical implications of damage to this transition zone remain understudied.
PURPOSE UNASSIGNED
To (1) report minimum 8-year survivorship and patient-reported outcome measures after hip arthroscopy for FAI and (2) characterize associations between outcomes and patient characteristics (age, body mass index, sex), pathological parameters (Tönnis angle, alpha angle, type of FAI, CLJ breakdown), and procedures performed (labral management, FAI treatment, microfracture).
STUDY DESIGN UNASSIGNED
Cohort study; Level of evidence, 3.
METHODS UNASSIGNED
This retrospective cohort study included patients who underwent primary hip arthroscopy for symptomatic labral tears secondary to FAI by a single surgeon between 2002 and 2013. All patients were ≥18 years of age with minimum 8-year follow-up and available preoperative radiographs. The primary outcome was conversion to total hip arthroplasty (THA), and secondary outcomes included revision arthroscopy, patient-reported outcome measures, and patient satisfaction. CLJ breakdown was assessed using the Beck classification. Kaplan-Meier estimates and weighted Cox regression were used to estimate 10-year survivorship (no conversion to THA) and identify risk factors associated with THA conversion.
RESULTS UNASSIGNED
In this study of 174 hips (50.6% female; mean age, 37.8 ± 11.2 years) with mean follow-up of 11.1 ± 2.5 years, the 10-year survivorship rate was 81.6% (95% CI, 75.9%-87.7%). Conversion to THA occurred at a mean 4.7 ± 3.8 years postoperatively. Unadjusted analyses revealed several variables significantly associated with THA conversion, including older age; higher body mass index; higher Tönnis grade; labral debridement; and advanced breakdown of the CLJ, labrum, or articular cartilage. Survivorship at 10 years was inferior in patients exhibiting severe (43.6%; 95% CI, 31.9%-59.7%) versus mild (97.9%; 95% CI, 95.1%-100%) breakdown of the CLJ (
CONCLUSION UNASSIGNED
Although most patients achieved favorable minimum 8-year outcomes, several pre- and intraoperative factors were associated with THA conversion; of these, worse CLJ breakdown, higher Tönnis grade, and older age were the strongest predictors.

Identifiants

pubmed: 38476016
doi: 10.1177/03635465241234258
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3635465241234258

Déclaration de conflit d'intérêts

One or more of the authors has declared the following potential conflict of interest or source of funding: This study was supported by the Conine Family Fund for Joint Preservation. C.W. has received support for education from Smith & Nephew and hospitality payments from Exactech. S.D.M. has received support for education from Kairos Surgical and a gift from Allergan. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.

Auteurs

Michael C Dean (MC)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Nathan J Cherian (NJ)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Orthopaedic Surgery, University of Nebraska, Omaha, Nebraska, USA.

Zachary L LaPorte (ZL)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Christopher T Eberlin (CT)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Orthopaedic Surgery, University of Iowa, Iowa City, Iowa, USA.

Charles Wang (C)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Kaveh A Torabian (KA)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Kieran S Dowley (KS)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Michael P Kucharik (MP)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Orthopaedic Surgery, University of South Florida, Tampa, Florida, USA.

Paul F Abraham (PF)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Orthopaedic Surgery, University of Southern California, Los Angeles, California, USA.

Mark R Nazal (MR)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Orthopaedic Surgery, University of Kentucky, Lexington, Kentucky, USA.

Scott D Martin (SD)

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Classifications MeSH